Evidence map›Paper›PMID 39890881›Full record

ArticleScientific reports2025

Revealing the critical state and identifying individualized dynamic network biomarker for type 2 diabetes through advanced analysis methods on individual basis.

Peiyu Li, Shaowen Jing, Guo Tian, Jing Jiang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Peiyu LiNetwork and Informatization Office, Henan University of Science and Technology, Luoyang, China. lpy@haust.edu.cn.
Shaowen JingNetwork and Informatization Office, Henan University of Science and Technology, Luoyang, China.
Guo TianNetwork and Informatization Office, Henan University of Science and Technology, Luoyang, China.
Jing JiangSchool of Mathematics and Statistics, Henan University of Science and Technology, Luoyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Complex diseases may not always progress in a gradual manner. In the early stages of complex diseases, obvious symptoms are usually not observable, but there is a commonality: there is a brief state of predisease between the progression from normal state to disease state, which usually includes three stages: normal state, critical state of predisease, and disease state. Identifying this critical state, especially with a single sample from an individual, remains a difficult task. In this study, we applied three methods, i.e., single-sample Jensen-Shannon Divergence (sJSD), network information gain (NIG), and temporal network flow entropy (TNFE) method, to a simulated dataset and type 2 diabetes (GSE13268 and GSE13269). Three different methods were utilized to create indexes, including the Inconsistency Index (ICI), NIG, and TNFE, to measure the overall disruption caused by individual samples compared to a set of reference samples. Changes in these indexes were used to identify critical states during the progression of the disease. Results from the numerical simulations show the effectiveness of the three methods. All the methods can detect two critical states based on a single sample, which are respectively at 8 weeks and 16 weeks for GSE13268 and at 4 weeks and 16 weeks for GSE13269, indicating the critical states before deterioration can be detected and the dynamic network biomarkers (DNBs) can be identified successfully. But there are differences in the sensitivity of predictive indicators based on the three methods. The identified dynamic network biomarkers are also significantly different. In addition, the computational principles of the three methods are compared. The proposed three methods can effectively detect the critical state and identify the DNB, solely based on a single sample. The three methods are data-driven and model-free on an individual basis. sJSD method is more sensitive to the critical state, while NIG and TNFE methods are more robust and effective. They can therefore not only help future studies of personalized disease diagnosis but also provide a better insight into clinical practice.

Indexed as

BiomarkersDiabetes Mellitus, Type 2AlgorithmsComputational BiologyComputer SimulationDisease ProgressionGene Regulatory NetworksHumansBiomarkersCritical stateDynamic network biomarkerNetwork information gain (NIG)Single-sample Jensen–Shannon Divergence (sJSD)Temporal network flow entropy (TNFE)

Identifiers

PMID39890881
PMCPMC11785715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.